Growing Demand for Rapid Screening Technologies in North America

The North American toxicology laboratories market is set to expand significantly, with an expected CAGR of 10.4% from 2023 to 2030. Rapid screening technologies are at the forefront of this growth, enabling faster and more accurate detection of toxic substances. The market size, valued at US$255.2 million in 2023, is projected to reach US$511.2 million by 2030. The demand for these technologies is particularly strong in the pharmaceutical, food, and chemical industries, where safety regulations are stringent. The U.S. and Canada, known for their rigorous testing standards, are key drivers of this market expansion. Additionally, advancements in mass spectrometry, genomics, and bioinformatics are contributing to more precise toxicology testing, allowing for earlier detection of potential hazards. The integration of informatics and data solutions further enhances the market's capabilities, ensuring that confidential test results are securely managed. As the market evolves, companies are increasingly outsourcing toxicology testing to specialized laboratories, accessing advanced technology without the need for significant in-house investments. This trend is expected to continue, further fueling the market's growth and solidifying North America's position as a leader in toxicology testing.